Pictet Asset Management (Switzerland)’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $36.4M | Buy |
5,175,080
+4,210,788
| +437% | +$29.6M | 0.04% | 348 |
|
|
2023
Q1 | $5.89M | Buy |
964,292
+524,583
| +119% | +$3.21M | 0.01% | 742 |
|
|
2022
Q4 | $2.81M | Sell |
439,709
-3,542,635
| -89% | -$22.6M | ﹤0.01% | 863 |
|
|
2022
Q3 | $38.2M | Buy |
3,982,344
+349,506
| +10% | +$3.35M | 0.06% | 316 |
|
|
2022
Q2 | $40.1M | Buy |
3,632,838
+1,048,129
| +41% | +$11.6M | 0.06% | 325 |
|
|
2022
Q1 | $43M | Buy |
2,584,709
+373,577
| +17% | +$6.22M | 0.05% | 341 |
|
|
2021
Q4 | $42.2M | Buy |
2,211,132
+1,213,057
| +122% | +$23.2M | 0.04% | 373 |
|
|
2021
Q3 | $24.6M | Buy |
+998,075
| New | +$24.6M | 0.03% | 469 |
|